Case Report: Tocilizumab for the Treatment of SARS-CoV-2 Infection in a Patient With Aplastic Anemia

Case Report: Tocilizumab for the Treatment of SARS-CoV-2 Infection in a Patient With Aplastic Anemia

While cytokine storm develops in a minority of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, novel treatment approaches are desperately needed for those in whom it does. Tocilizumab, an interleukin-6 receptor antibody, has been utilized for the treatment of cy...

Full description

Bibliographic Details
Main Authors: Gina Keiffer, Zachary French, Lindsay Wilde, Joanne Filicko-O'Hara, Usama Gergis, Adam F. Binder
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Oncology
Subjects:
COVID-19
SARS-CoV-2
tocilizumab
cytokine storm
aplastic anemia
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.562625/full

Similar Items

Similar Items